Company dossier
GlaxoSmithKline Pharmaceuticals
NSE:GLAXO · ISIN INE159A01016
- Close
- ₹2,626.4 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
GlaxoSmithKline Pharmaceuticals
Intelligence
Event intelligence
One event, every source
Exchange filings establish the evidence spine. Related reporting, commentary and corrections will join the same event instead of appearing as disconnected links.
- Events
- 0
- Primary-backed
- 0
- Source families
- 0
- News matched
- 0
Material event stream
0 clustersWhat changed at GlaxoSmithKline Pharmaceuticals
No reconciled records in this module yet
No event clusters are available yet. The official filing sync will create the first evidence-backed event spine.
Daily news discovery
0 matchedReporting linked to GlaxoSmithKline Pharmaceuticals
No reconciled records in this module yet
No publisher headlines have passed deterministic company matching yet. Query-only and ambiguous results stay in review instead of being attached to this page.